Characterisation of snake venom components and screening venom for bioactive compounds. Animal venoms are a rich source of bioactive compounds. This project will separate and characterise the protein-containing components of the North Queensland taipan. It will also involve constructing a cDNA library from mRNA isolated from the venom glands of the same snake and individual clones will be isolated and sequenced. Individual snake venom components, purified either from whole snake venom or synthes ....Characterisation of snake venom components and screening venom for bioactive compounds. Animal venoms are a rich source of bioactive compounds. This project will separate and characterise the protein-containing components of the North Queensland taipan. It will also involve constructing a cDNA library from mRNA isolated from the venom glands of the same snake and individual clones will be isolated and sequenced. Individual snake venom components, purified either from whole snake venom or synthesised via in vivo expression, will be tested in a variety of rapid throughput screening assays to identify specific bioactivities. This project will train a post graduate scientist in methods involved in the discovery of novel bioactive compounds.Read moreRead less
Improving dairy cow fertility: targeting exosome-responsive cell pathways. . This project aims to assist the dairy industry to achieve its goal of increasing the six-week in-calf pregnancy rate in dairy cows by at least 10 per cent within five years via the identification of circulating exosomal biomarkers of improved fertility that will be used to develop superior breeding stock to deliver higher industry productivity. The impact of novel biomarkers will permit the Australian and New Zealand da ....Improving dairy cow fertility: targeting exosome-responsive cell pathways. . This project aims to assist the dairy industry to achieve its goal of increasing the six-week in-calf pregnancy rate in dairy cows by at least 10 per cent within five years via the identification of circulating exosomal biomarkers of improved fertility that will be used to develop superior breeding stock to deliver higher industry productivity. The impact of novel biomarkers will permit the Australian and New Zealand dairy industries to meet their targets and provide economic benefit to the respective industries, whilst ensuring availability of low cost milk to Australian citizens.Read moreRead less
Epigenetic and biomarker approaches to improving dairy cow fertility. The dairy industry will not deliver sustainable higher productivity unless the reproductive performance of dairy cows is significantly improved. This expected outcome will be achieved via the identification of epigenetic and protein biomarkers of improved fertility that will be used to develop superior breeding stock. Caruncular and intercaruncular tissues and blood have been obtained from both fertile (New Zealand Holstein-Fr ....Epigenetic and biomarker approaches to improving dairy cow fertility. The dairy industry will not deliver sustainable higher productivity unless the reproductive performance of dairy cows is significantly improved. This expected outcome will be achieved via the identification of epigenetic and protein biomarkers of improved fertility that will be used to develop superior breeding stock. Caruncular and intercaruncular tissues and blood have been obtained from both fertile (New Zealand Holstein-Friesian) and sub-fertile (North American Holstein-Friesian) cows within pasture-based dairying systems that include seasonal calving and subclinical uterine inflammation (associated with poor reproductive performance). Determinations will be conducted using deep parallel (next generation) sequencing and mass spectrometry.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE180100043
Funder
Australian Research Council
Funding Amount
$435,279.00
Summary
High-throughput portable and wearable device fabrication facility. This project aims to establish a fabrication and characterisation facility for high-throughput production of portable, wearable and stretchable biomedical devices to accelerate the design–fabrication–evaluation process and save ‘trial-and-error’ costs during optimisation turnaround. It will apply computer-aided design for the programmable synthesis of hybrid materials for high-throughput screening of disease biomarkers, and super ....High-throughput portable and wearable device fabrication facility. This project aims to establish a fabrication and characterisation facility for high-throughput production of portable, wearable and stretchable biomedical devices to accelerate the design–fabrication–evaluation process and save ‘trial-and-error’ costs during optimisation turnaround. It will apply computer-aided design for the programmable synthesis of hybrid materials for high-throughput screening of disease biomarkers, and super-solution imaging of single molecules in live cells. This facility will provide capability for researchers pursuing industry transformation and other initiatives in the development of advanced materials, biomolecular sciences, nanotechnology, photonics and device engineering.Read moreRead less
Industrial Transformation Research Hubs - Grant ID: IH150100028
Funder
Australian Research Council
Funding Amount
$3,708,510.00
Summary
ARC Research Hub for Integrated Device for End-user Analysis at Low-levels. ARC Research Hub for Integrated Device for End-user Analysis at Low-levels. This hub aims to improve detection of biological materials by building a portable device for rapid, time-critical detection of low-abundance molecular and cellular analytes. It is expected that the resulting technologies would be used at medical points of care, ordinary workplaces and centres of activity to test for tiny levels of targeted molecu ....ARC Research Hub for Integrated Device for End-user Analysis at Low-levels. ARC Research Hub for Integrated Device for End-user Analysis at Low-levels. This hub aims to improve detection of biological materials by building a portable device for rapid, time-critical detection of low-abundance molecular and cellular analytes. It is expected that the resulting technologies would be used at medical points of care, ordinary workplaces and centres of activity to test for tiny levels of targeted molecules. The initial focus would be early diagnosis of disease and point-of-care drug testing for humans and animals, but the technology platform could be used to sample food and environmental toxins. The hub expects these disruptive technologies will make Australian biotechnology, diagnostics, veterinary, agribusiness and manufacturing firms globally competitive.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0775726
Funder
Australian Research Council
Funding Amount
$306,270.00
Summary
Australian Mirror of the UCSC Genome Database and Browser. Modern medical, biological, agricultural, and environmental research and industries are being transformed by access to genomic information that details the DNA sequence of various species, as well as of different strains and individuals within populations. This information is being generated at an exponentially increasing speed, and requires large computational resources. This facility will provide Australian researchers, R&D organizati ....Australian Mirror of the UCSC Genome Database and Browser. Modern medical, biological, agricultural, and environmental research and industries are being transformed by access to genomic information that details the DNA sequence of various species, as well as of different strains and individuals within populations. This information is being generated at an exponentially increasing speed, and requires large computational resources. This facility will provide Australian researchers, R&D organizations and industry with state-of-the-art genomic data storage and analysis capability, which will permit both public and proprietary access, and accelerate Australian research and development in genetic medicine, pharmaceuticals, animal breeding and biodiversity.Read moreRead less
Identification of at-risk transition cows: Use of exosomal biomarkers. This project aims to improve the early diagnosis of cows at risk of infectious disease and debilitating metabolic syndromes. Animal health and longevity are pillars of the dairy industry. The risk of death is up to 6 times greater during the transition from pregnancy to lactation, making this ‘transition period’ the time for detection and intervention. If successful, this project will permit the focus of resources on high ris ....Identification of at-risk transition cows: Use of exosomal biomarkers. This project aims to improve the early diagnosis of cows at risk of infectious disease and debilitating metabolic syndromes. Animal health and longevity are pillars of the dairy industry. The risk of death is up to 6 times greater during the transition from pregnancy to lactation, making this ‘transition period’ the time for detection and intervention. If successful, this project will permit the focus of resources on high risk cows and reduce poor outcomes: lower milk production, involuntary culling and increased cow maintenance costs. Within this overall objective, a cost-effective project design will leverage partner facilities and existing networks to translate findings to farm use, thereby clearly delivering economic value.Read moreRead less
Ex vivo production of neutrophils. Relentless infections frequently occur in patients receiving intensive chemotherapy treatment. Chemotherapy is toxic to the bone marrow where blood cells are produced. A low white blood cell count and in particular a low neutrophil count is linked with infection in these patients. Unlike red cells and platelets, neutrophils are difficult to collect from blood donors and hence are not routinely available. In this project, we will develop a practical, cost effic ....Ex vivo production of neutrophils. Relentless infections frequently occur in patients receiving intensive chemotherapy treatment. Chemotherapy is toxic to the bone marrow where blood cells are produced. A low white blood cell count and in particular a low neutrophil count is linked with infection in these patients. Unlike red cells and platelets, neutrophils are difficult to collect from blood donors and hence are not routinely available. In this project, we will develop a practical, cost efficient process for the production of neutrophils from cord blood. Transfusion of these neutrophils should reduce the chance of patients suffering serious infection, allow them to recover faster from their chemotherapy, and reduce the need for admission to intensive care.Read moreRead less
EX VIVO PRODUCTION OF MATURE RED BLOOD CELLS FOR TRANSFUSION. This project aims to establish a practical, cost efficient biotechnology platform for the expansion and maturation of blood stem cells to produce blood transfusion products. Red blood cell production will be used as the prototype model. It is envisaged that blood bioreactors will initially supplement and ultimately replace the current blood donor based process, thus overcoming the on-going donor recruitment, retention and safety issue ....EX VIVO PRODUCTION OF MATURE RED BLOOD CELLS FOR TRANSFUSION. This project aims to establish a practical, cost efficient biotechnology platform for the expansion and maturation of blood stem cells to produce blood transfusion products. Red blood cell production will be used as the prototype model. It is envisaged that blood bioreactors will initially supplement and ultimately replace the current blood donor based process, thus overcoming the on-going donor recruitment, retention and safety issues associated with collection of single units of blood. This project is focused on providing solutions to two key technical and economical challenges: (a) achieving full maturation of red blood cells and (b) achieving at least a 100-fold intensification of the expansion and maturation process through perfusion.Read moreRead less
Industrial Transformation Training Centres - Grant ID: IC130100009
Funder
Australian Research Council
Funding Amount
$2,100,000.00
Summary
ARC Training Centre for Molecular Technology in the Food Industry. A molecular technology platform for enabling the next revolution in the food industry. Society needs new approaches for solving the difficulties of providing enough food for the future. This Training Centre will train young scientists in the application of applying molecular analysis skills to solve specific problems that the food industry faces in the whole process of taking food production from “field to fork”.